Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7645747 Therapeutic phosphonate compounds

Patent 7645747 was granted and assigned to Gilead Sciences on January, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
October 25, 2005
0
Date of Patent
January 12, 2010
0
Patent Application Number
11258621
0
Patent Citations Received
‌
US Patent 12122833 Combination therapies of HDAC inhibitors and PD-1 inhibitors
0
Patent Inventor Names
Hyung-Jung Pyun
0
William A. Lee
0
William J. Watkins
0
Xiaowu Chen
0
Adrian S. Ray
0
Aesop Cho
0
Alan X. Huang
0
Carina E. Cannizzaro
0
Choung U. Kim
0
Christopher P. Lee
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7645747
0
Patent Primary Examiner
‌
Rebecca L Anderson
0

Find more entities like US Patent 7645747 Therapeutic phosphonate compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.